What is Zynex Operating Cash Flow per Share?
Zynex's operating cash flow per share for the
three
months ended in Dec. 2023 was $0.18.
Zynex's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.50.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Zynex was 39.90% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 185.90% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 24.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Zynex's Operating Cash Flow per Share or its related term are showing as below:
ZYXI'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -54.7 Med: 38.35 Max: 192.8
Current: 185.9
During the past 13 years, Zynex's highest 3-Year average Operating Cash Flow per Share Growth Rate was 192.80% per year. The lowest was -54.70% per year. And the median was 38.35% per year.
Zynex Operating Cash Flow per Share Historical Data
The historical data trend for Zynex's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zynex Operating Cash Flow per Share Chart
|
Zynex Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Operating Cash Flow per Share |
|
Get a 7-Day Free Trial
|
|
|
0.17 |
0.02 |
0.18 |
0.35 |
0.49 |
|
Zynex Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Operating Cash Flow per Share |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
0.13 |
0.05 |
0.02 |
0.25 |
0.18 |
Competitive Comparison of Zynex's Operating Cash Flow per Share
For the Medical Distribution subindustry, Zynex's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zynex's Price-to-Operating-Cash-Flow Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Zynex's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Zynex's Price-to-Operating-Cash-Flow falls into.
Zynex Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Zynex's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Zynex's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.50
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zynex (ZYXI) Business Description
Traded in Other Exchanges
N/A
Address
9555 Maroon Circle, Englewood, CO, USA, 80112
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. it also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave and others.
Executives
| Daniel J Moorhead |
officer: Chief Financial Officer |
9777 PYRAMID CT, STE 100, ENGLEWOOD CO 80112 |
| Anna Lucsok |
officer: See Remarks |
9555 MAROON CIRCLE, ENGLEWOOD CO 80112 |
| Thomas Sandgaard |
director, 10 percent owner, officer: President, CEO and Chairman |
10506 KALAHARI CT., LONE TREE CO 80124 |
| Neil Friery |
officer: See Remarks |
C/O ZYNEX, INC. 9555 MAROON CIRCLE, ENGLEWOOD CO 80112 |
| Joshua R. Disbrow |
director |
AMPIO PHARMACEUTICALS, INC., 5445 DTC PARKWAY, SUITE 925, GREENWOOD VILLAGE CO 80111 |
| Barry D Michaels |
director |
6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121 |
| Michael D Cress |
director |
3409 ESPERANZA CROSSING SUITE 7110, AUSTIN TX 78758 |
| Sandgaard Holdings Llc |
10 percent owner |
9555 MAROON CIRCLE, ENGLEWOOD CO 80112 |
| Giuseppe Papandrea |
officer: Chief Operating Officer |
C/O ZYNEX, INC. 9555 MAROON CIRCLE, ENGLEWOOD CO 80112 |
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZYXI has been successfully added to your